Duy Cong Tran, MD
Dermatology · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tran’s office at (408) 739-6000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A186792 · Current
Licensed to practise in California · since 2023 · expires 2027-06-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$119,321
Medicare paid this office $119,321 for 414 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 157 | $28,357 | $111 |
| Destruction of skin growth, 1-14 growths | 122 | $16,836 | $112 |
| Short return visit (20+ min) | 139 | $15,145 | $76 |
| New patient visit (45+ min) | 87 | $11,824 | $136 |
| Biopsy of related skin growth, first growth | 101 | $9,144 | $86 |
See all 11 services
| Return visit (30+ min) | 157 | $28,357 | $111 |
| Destruction of skin growth, 1-14 growths | 122 | $16,836 | $112 |
| Short return visit (20+ min) | 139 | $15,145 | $76 |
| New patient visit (45+ min) | 87 | $11,824 | $136 |
| Biopsy of related skin growth, first growth | 101 | $9,144 | $86 |
| Destruction of precancer skin growth, 1 growth | 143 | $8,597 | $46 |
| New patient visit (30+ min) | 83 | $7,514 | $91 |
| Destruction of precancer skin growth, 2-14 growths | 105 | $4,765 | $7 |
| Destruction of precancer skin growth, 15 or more growths | 15 | $3,144 | $165 |
| Long return visit (40+ min) | 15 | $2,697 | $159 |
| Application of ultraviolet light to skin | 20 | $1,002 | $26 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 531 | More than 87% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 135 | More than 79% of doctors who do this |
Who their Medicare patients are
414 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 17% · Women 49% · Also on Medicaid 10% · Health risk score 0.96. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 62% · Diabetes 21% · Chronic kidney disease 20% · Coronary heart disease 18% · Cancer 18% · Depression 15% · Atrial fibrillation 14% · Heart failure 11% · COPD 7% · Stroke 5% · Dementia 4%.
The office billed $429,215, Medicare allowed $163,952 and paid $119,321; for 1,946 services of 46 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 414 | 1,946 | 76 | 0.96 | $429,215 | $119,321 |
| 2023 | 191 | 692 | 75 | 0.96 | $155,290 | $45,696 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 58 | $8,577 | $117 |
| Short return visit (20+ min) | 55 | $5,043 | $87 |
| Biopsy of related skin growth, first growth | 49 | $4,941 | $97 |
| Destruction of skin growth, 1-14 growths | 31 | $4,206 | $117 |
| New patient visit (30+ min) | 41 | $4,109 | $100 |
| New patient visit (45+ min) | 26 | $3,970 | $153 |
| Destruction of precancer skin growth, 1 growth | 47 | $2,676 | $50 |
| Application of ultraviolet light to skin | 28 | $2,307 | $26 |
| Destruction of precancer skin growth, 2-14 growths | 38 | $1,389 | $7 |
Drugs they prescribed that Part D paid
$146,145
Pharmacies billed $146,145 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 626) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
595 generic and 31 brand-name prescriptions · $146,145 in drug cost · 23 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 12 | $49,289 | $4,107 |
| Tacrolimus | 24 | $4,046 | $169 |
| Ketoconazole | 141 | $2,361 | $17 |
| Clobetasol Propionate | 29 | $1,925 | $66 |
| Triamcinolone Acetonide | 112 | $1,377 | $12 |
See all 15 drugs
| Dupixent | 12 | $49,289 | $4,107 |
| Tacrolimus | 24 | $4,046 | $169 |
| Ketoconazole | 141 | $2,361 | $17 |
| Clobetasol Propionate | 29 | $1,925 | $66 |
| Triamcinolone Acetonide | 112 | $1,377 | $12 |
| Fluorouracil | 13 | $1,020 | $78 |
| Desonide | 23 | $891 | $39 |
| Mometasone Furoate | 29 | $657 | $23 |
| Fluocinonide | 13 | $497 | $38 |
| Fluocinolone Acetonide | 13 | $453 | $35 |
| Mupirocin | 46 | $326 | $7 |
| Econazole Nitrate | 12 | $258 | $22 |
| Doxycycline Monohydrate | 12 | $197 | $16 |
| Hydrocortisone | 39 | $174 | $4 |
| Prednisone | 12 | $60 | $5 |
Year by year
| 2024 | 626 | 235 | 0% (0) | 5% | $146,145 |
| 2023 | 211 | 114 | 0% (0) | 7% | $30,838 |
| 2022 | 255 | 86 | 0% (0) | 11% | $65,777 |
| 2021 | 201 | 64 | 0% (0) | 16% | $42,371 |
| 2020 | 152 | 45 | 0% (0) | 11% | $83,065 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Ketoconazole | 40 | $924 | $23 |
| Triamcinolone Acetonide | 31 | $368 | $12 |
| Mupirocin | 11 | $96 | $9 |
| Hydrocortisone | 14 | $72 | $5 |
2022: 5 drugs
| Halobetasol Propionate | 15 | $1,456 | $97 |
| Clobetasol Propionate | 22 | $1,362 | $62 |
| Ketoconazole | 28 | $802 | $29 |
| Triamcinolone Acetonide | 35 | $474 | $14 |
| Mupirocin | 16 | $153 | $10 |
2021: 4 drugs
| Clobetasol Propionate | 18 | $1,924 | $107 |
| Ketoconazole | 42 | $956 | $23 |
| Clindamycin Phosphate | 11 | $473 | $43 |
| Triamcinolone Acetonide | 19 | $313 | $16 |
2020: 2 drugs
| Ketoconazole | 34 | $380 | $11 |
| Triamcinolone Acetonide | 16 | $237 | $15 |
Money from drug and device companies
$2,414 in 2025
| 2025 | 14 | 70 | None | $2,414 |
| 2024 | 14 | 51 | None | $2,117 |
| 2023 | 4 | 12 | None | $2,819 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Biotech | Tremfya | $751 | 20 payments
|
| Genzyme | Dupixent | $402 | 5 payments
|
| Incyte | Opzelura | $373 | 17 payments
|
| Regeneron Pharmaceuticals | Dupixent | $212 | 2 payments
|
| Abbvie | Mavyret | $122 | 2 payments
|
| Arcutis Biotherapeutics | Zoryve | $115 | 6 payments
|
See all 70 published payments
| Incyte | Meals · 2025-12-17 | Opzelura | $1 |
| Incyte | Meals · 2025-12-17 | Opzelura | $19 |
| Janssen Biotech | Meals · 2025-12-15 | Tremfya | $18 |
| Galderma Laboratories L.P. | Meals · 2025-12-11 | Nemluvio | $18 |
| Incyte | Meals · 2025-12-09 | Opzelura | $11 |
| Incyte | Meals · 2025-12-02 | Opzelura | $17 |
| Incyte | Meals · 2025-12-02 | Opzelura | $4 |
| Arcutis Biotherapeutics | Meals · 2025-11-20 | Zoryve | $31 |
| Janssen Biotech | Meals · 2025-11-17 | Tremfya | $10 |
| Janssen Biotech | Meals · 2025-11-17 | Tremfya | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-06 | Sotyktu | $32 |
| Incyte | Meals · 2025-11-04 | Opzelura | $26 |
| Incyte | Meals · 2025-10-21 | Opzelura | $29 |
| Genzyme | Meals · 2025-10-20 | Dupixent | $47 |
| Arcutis Biotherapeutics | Meals · 2025-10-16 | Zoryve | $16 |
| Lilly USA | Meals · 2025-10-13 | Taltz | $32 |
| Novartis Pharmaceuticals | Meals · 2025-10-09 | Rhapsido | $21 |
| Incyte | Meals · 2025-10-08 | Opzelura | $6 |
| Incyte | Meals · 2025-10-07 | Opzelura | $26 |
| Janssen Biotech | Meals · 2025-09-24 | Tremfya | $26 |
| Incyte | Meals · 2025-09-24 | Opzelura | $10 |
| Janssen Biotech | Meals · 2025-09-19 | Tremfya | $146 |
| Arcutis Biotherapeutics | Meals · 2025-09-16 | Zoryve | $19 |
| Janssen Biotech | Meals · 2025-09-15 | Tremfya | $14 |
| Incyte | Meals · 2025-09-15 | Opzelura | $17 |
| Incyte | Meals · 2025-09-10 | Opzelura | $13 |
| Janssen Biotech | Meals · 2025-08-21 | Tremfya | $27 |
| Regeneron Pharmaceuticals | Meals · 2025-08-16 | Dupixent | $123 |
| Regeneron Healthcare Solutions | Meals · 2025-08-14 | Dupixent | $38 |
| Galderma Laboratories L.P. | Meals · 2025-08-11 | None | $18 |
| Janssen Biotech | Meals · 2025-08-04 | Tremfya | $23 |
| Galderma Laboratories L.P. | Meals · 2025-08-04 | Nemluvio | $23 |
| Organon | Meals · 2025-07-31 | None | $27 |
| Organon | Meals · 2025-07-22 | Vtama | $26 |
| Arcutis Biotherapeutics | Meals · 2025-07-22 | Zoryve | $16 |
| Janssen Biotech | Meals · 2025-07-21 | Tremfya | $35 |
| Janssen Biotech | Meals · 2025-07-14 | Tremfya | $34 |
| Janssen Biotech | Meals · 2025-07-09 | Tremfya | $26 |
| Janssen Biotech | Education · 2025-07-08 | Tremfya | $99 |
| Janssen Biotech | Meals · 2025-06-26 | Tremfya | $36 |
| Arcutis Biotherapeutics | Meals · 2025-06-16 | Zoryve | $17 |
| Incyte | Meals · 2025-06-12 | Opzelura | $133 |
| Janssen Biotech | Meals · 2025-06-11 | Tremfya | $28 |
| Abbvie | Meals · 2025-06-09 | Mavyret | $87 |
| Genzyme | Meals · 2025-05-20 | Dupixent | $41 |
| Novartis Pharmaceuticals | Meals · 2025-05-08 | Cosentyx | $18 |
| Janssen Biotech | Meals · 2025-05-06 | Tremfya | $25 |
| Janssen Biotech | Meals · 2025-05-06 | Tremfya | $3 |
| Janssen Biotech | Meals · 2025-05-02 | Tremfya | $20 |
| Genzyme | Meals · 2025-05-01 | Dupixent | $125 |
| Lilly USA | Meals · 2025-04-28 | Taltz | $25 |
| Incyte | Meals · 2025-04-22 | Opzelura | $31 |
| Incyte | Meals · 2025-04-18 | Opzelura | $2 |
| Regeneron Healthcare Solutions | Meals · 2025-04-17 | Dupixent | $29 |
| Genzyme | Meals · 2025-03-27 | Dupixent | $146 |
| Lilly USA | Meals · 2025-03-24 | Ebglyss | $22 |
| Regeneron Pharmaceuticals | Meals · 2025-03-09 | Dupixent | $89 |
| Almirall | Meals · 2025-02-11 | Klisyri | $19 |
| Janssen Biotech | Meals · 2025-02-05 | Tremfya | $21 |
| Incyte | Meals · 2025-02-05 | Opzelura | $2 |
| Incyte | Meals · 2025-02-05 | Opzelura | $24 |
| Genzyme | Meals · 2025-02-03 | Dupixent | $42 |
| Lilly USA | Meals · 2025-01-29 | Taltz | $17 |
| Novartis Pharmaceuticals | Meals · 2025-01-28 | Cosentyx | $27 |
| Janssen Biotech | Meals · 2025-01-22 | Tremfya | $121 |
| Abbvie | Meals · 2025-01-21 | Skyrizi | $35 |
| Ucb | Meals · 2025-01-16 | Bimzelx | $24 |
| Janssen Biotech | Meals · 2025-01-15 | Tremfya | $26 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-13 | Sotyktu | $22 |
| Arcutis Biotherapeutics | Meals · 2025-01-10 | Zoryve | $16 |
See earlier years (2024, 2023)
2024: $2,117
| Genzyme | Dupixent | $459 | 9 payments
|
| Dermavant Sciences | Vtama | $354 | 9 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $240 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $220 | 5 payments
|
| Lilly USA | Taltz | $185 | 3 payments
|
| Janssen Biotech | Tremfya | $155 | 2 payments
|
| Incyte | Opzelura | $105 | 4 payments
|
| Regeneron Pharmaceuticals | Dupixent | $92 | 1 payment
|
| Ucb | Bimzelx | $92 | 3 payments
|
| Arcutis Biotherapeutics | Zoryve | $76 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $50 | 2 payments
|
| Almirall | Klisyri | $33 | 2 payments
|
| STRATA Skin Sciences | Xtrac | $30 | 1 payment
|
| Galderma Laboratories L.P. | None | $25 | 1 payment
|
2023: $2,819
| AbbVie | Revolve | $2,302 | 7 payments
|
| Galderma Laboratories L.P. | None | $273 | 2 payments
|
| Incyte | Opzelura | $153 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $91 | 1 payment
|
Professional record
- NPI
- 1679035208
- Licence
- CA A186792California A186792: Current · expires 2027-06-30
- Trained
- Stanford University School of Medicine, 2019
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2019-04-02
- NPI last updated
- 2023-08-22
- NPI record certified
- 2023-08-22
This is when the NPI record was last certified, not a medical board exam.